WHO restructuring after IGWG stalemate
The World Health Organization's Director General, Margaret Chan, has announced a new round of changes to the global body's structure. As a result, the Health Technology and Pharmaceuticals cluster will be merged into the Health Systems and Services cluster.
The WHO's assistant director, Howard Zucker, is leaving "to pursue other opportunities," soon after the inconclusive recent Inter-Governmental Working Group meeting on innovation and intellectual property which he headed (Marketletter November 19). The International Federation of Pharmaceutical Associations and Manufacturers said the merger would "create a powerful body" under a new leader following the imminent departure of Anders Nordstrom. A spokesman for the IFPMA told the Marketletter that it awaits news of the new appointee "with interest."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze